In Vitro Bactericidal Activity of Next-Generation Polymyxin SPR206 against Susceptible and Multidrug-Resistant (MDR) Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniaeas as compared to Levofloxacin and Meropenem

In Vitro Bactericidal Activity of Next-Generation Polymyxin SPR206 against Susceptible and Multidrug-Resistant (MDR) Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniaeas as compared to Levofloxacin and Meropenem